Market Overview

The Global Biopsy Devices Market was valued at USD 7,698.1 million in 2023 and is expected to reach USD 23,061.6 million by 2031 while growing at a CAGR of 14.7% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global biopsy devices market growth. Biopsy devices are medical instruments utilized to extract samples of cells, tissues, or fluids from the body for diagnostic purposes. They play a crucial role in investigating suspicious lesions or abnormalities in organs or tissues, aiding in the diagnosis of conditions such as cancer, infections, and inflammatory diseases. These devices are engineered to collect samples from various anatomical sites with minimal trauma to surrounding tissues, ensuring accurate and reliable diagnostic results.

The biopsy devices market is driven by ongoing advancements in biopsy techniques, including minimally invasive procedures and image-guided biopsies, which enhance accuracy, safety, and patient comfort. Additionally, the increasing incidence of cancer contributes to market growth. However, barriers such as the high cost of biopsy procedures and limited reimbursement policies hinder market expansion.

Furthermore, the global biopsy devices industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Analysis

The Global Biopsy Devices Market is segmented among Needle-based Biopsy Instruments, Liquid Biopsy Instruments, Localization Wire, Biopsy Forceps, Procedure Tray, Biopsy Table, Others, based on Product. In 2023, Needle-based Biopsy Instruments accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Biopsy Devices Market is segmented among Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Application, based on Application. In 2023, Breast Cancer accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Biopsy Devices Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Becton, Dickinson and Company, Hologic Inc., Danaher Corporation, Cook Medical, Boston Scientific Corporation, Intact Medical Corporation, Gallini Medical, TSK Laboratory Europe BV, Argon Medical Devices, and B. Braun Melsungen AG .

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Biopsy Devices Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Biopsy Devices Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Biopsy Devices Market Segmentation, By Product

• Global Biopsy Devices Market Share Analysis, By Product

• Global Biopsy Devices Market Growth Analysis, By Product

• Global Biopsy Devices Market Trends, By Product

o Needle-based Biopsy Instruments

o Liquid Biopsy Instruments

o Localization Wire

o Biopsy Forceps

o Procedure Tray

o Biopsy Table

o Others

6. Global Biopsy Devices Market Segmentation, By Application

• Global Biopsy Devices Market Share Analysis, By Application

• Global Biopsy Devices Market Growth Analysis, By Application

• Global Biopsy Devices Market Trends, By Application

o Breast Cancer

o Lung Cancer

o Kidney Cancer

o Prostate Cancer

o Bone Marrow Biopsy

o Other Application

7. Global Biopsy Devices Market Segmentation, By Guidance technique

• Global Biopsy Devices Market Share Analysis, By Guidance technique

• Global Biopsy Devices Market Growth Analysis, By Guidance technique

• Global Biopsy Devices Market Trends, By Guidance technique

o Image Guided Biopsy

Ø     Ultrasound Guided Biopsy

Ø     Stereotactic Guided Biopsy

Ø     MRI Guided Biopsy

Ø     Other Biopsy

o Non-Image Guided Biopsy

Ø     Liquid Biopsy

Ø     General Biopsy

8. Global Biopsy Devices Market Segmentation, By End User

• Global Biopsy Devices Market Share Analysis, By End User

• Global Biopsy Devices Market Growth Analysis, By End User

• Global Biopsy Devices Market Trends, By End User

o Hospitals and Breast Care Centers

o Diagnostic Imaging Centers

o Research and Academic Institutes

o Other End Users

9. Global Biopsy Devices Market Segmentation, By Region

• Global Biopsy Devices Market Share Analysis, By Region

• Global Biopsy Devices Market Growth Analysis, By Region

• Global Biopsy Devices Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

• Becton, Dickinson and Company*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Hologic Inc.

• Danaher Corporation

• Cook Medical

• Boston Scientific Corporation

• Intact Medical Corporation

• Gallini Medical

• TSK Laboratory Europe BV

• Argon Medical Devices

• B. Braun Melsungen AG

*Similar analysis will be provided for each company listed above.